Expand SXTPW Menu
SXTPW MENU

SXTPW Latest Press Releases

-- February 2, 2026 --

60 Degrees Pharmaceuticals Expands Access to ARAKODA with GoodRx Partnership Globe Newswire 8:01 AM

-- January 28, 2026 --

60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use Globe Newswire 8:01 AM

-- January 22, 2026 --

60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA for Malaria Prevention Globe Newswire 8:01 AM

-- January 15, 2026 --

60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio Globe Newswire 8:01 AM

-- December 29, 2025 --

60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State Globe Newswire 8:01 AM

-- December 11, 2025 --

60 Degrees Pharmaceuticals Announces Expansion of ARAKODA Sales and Marketing in 2026 Globe Newswire 8:01 AM

-- November 21, 2025 --

60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine Globe Newswire 8:01 AM

-- November 13, 2025 --

60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results Globe Newswire 1:51 PM

-- October 15, 2025 --

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study Globe Newswire 7:14 AM

-- October 9, 2025 --

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study Globe Newswire 7:04 AM
Market Data Delayed 15 Minutes